TrialThe Journal of allergy and clinical immunology2019

Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps.

Yoshimasa Imoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.